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292 The Journal of Thoracic and Cardbjectives: Recent data have suggested that there is a flexibility of borderline values
f lung function tests in allowing safe lung resection. The aim of this study was to
ssess the pattern of postoperative lung function change in patients with chronic
bstructive pulmonary disease compared with that of patients with normal lung
unction, and to compare the operative morbidity and mortality between these
roups.
ethods: The study included 35 patients with chronic obstructive pulmonary
isease and a control group of 47 patients with normal lung function who underwent
ung resection for non–small cell lung cancer. The percent changes of lung function
arameters after lung resection and operative morbidity and mortality were com-
ared between groups.
esults: The mean postoperative loss in forced expiratory volume in the 1st second
as significantly less in patients with chronic obstructive pulmonary disease who
nderwent lobectomy compared with that of patients with normal lung function
11.88% vs 24.6%, P .05); forced expiratory flows at low lung volumes (50% and
5%) improved in patients who underwent lobectomy. The lung function change
fter pneumonectomy followed the same trend as that after lobectomy. In patients
ith chronic obstructive pulmonary disease, forced expiratory volume in the 1st
econd and small airways function significantly improved after preoperative bron-
hodilator therapy. In the group with chronic obstructive pulmonary disease, oper-
tive mortality was 0 and operative morbidity was 51.43%.
onclusions: Because the pattern of lung function change is different in patients
ith chronic obstructive pulmonary disease compared with that of patients with
ormal lung function, surgery can be offered to carefully selected patients with lung
ancer, even in the presence of severely limited lung function.
espiratory function directly influences the extent of lung resection. Whereas
the extent of resection directly influences the prognosis in patients with lung
cancer, respiratory function also has a direct effect on survival. Lung
esection in patients with chronic obstructive pulmonary disease (COPD) has been
ecognized as a major surgical challenge. In addition to the increased lung cancer
orbidity among patients with COPD, there is some evidence that COPD may also
e an obstacle in the diagnosis of lung cancer, making this association even more
omplex.1
The percent values of forced expiratory volume in the 1st second (FEV1), the
iffeneau index (100 FEV1/vital capacity [VC]), and the VC are now accepted as
iovascular Surgery ● November 2007
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G
TSimiting values for resection,2 instead of the absolute values
sed 15 years ago. Even if the FEV1 and 100 FEV1/VC
alues are less than 60% and 50%, respectively, resection
hould be not be rejected in a patient without previous
alculation of the predicted postoperative FEV1, usually by
erforming perfusion lung scintigraphy.3
In patients with limited lung function, any benefit from a
ossible cure must be weighed against the risk of long-term
isability or death. Despite much data, there is still no single
est to provide the answer in individual cases.4 It was
ecently shown that increased carbon monoxide diffusion in
he lung (DLCO) during effort is one of the most reliable
ethods to predict postoperative complications. An in-
rease in DLCO of less than 10% was associated with a
omplication rate of 100%, whereas an increase in DLCO of
ore than 10% from rest to 70% of maximal workload
expressed as a percent of the predicted DLCO at rest) was
ssociated with a complication rate of 10%.5 It is also well
stablished that the cutoff value of 15 mL/kg/min for oxy-
en consumption in effort is the best predictor of the overall
perative risk.6
Although controlled studies of lung resection in patients
ith limited lung function are relatively rare, recent data
onfirmed a different pattern of postoperative lung function
hange in patients with COPD compared with that of pa-
ients with normal lung function. These data, despite meth-
dologic heterogeneity, suggest that lower limits for lung
unction tests for safe lung resection are flexible and that
ung resection can sometimes be offered to patients in
hom surgery is rejected.7
The aim of this study was to 1) assess the pattern of
ostoperative lung function change in patients with limited
ung function compared with patients with normal lung
unction; 2) compare operative morbidity and mortality
etween these groups; and 3) assess the contribution of
ombined bronchodilator therapy to the outcome of the
reatment of patients with COPD.
aterials and Methods
atient Characteristics
he prospective study included 35 patients with limited respiratory
unction who underwent lung resection for primary non–small cell
ung cancer in a 2-year period. There were 28 men and 7 women
Abbreviations and Acronyms
COPD chronic obstructive pulmonary disease
DLCO carbon monoxide diffusion capacity in the
lung
FEF  forced expiratory flow
FEV1  forced expiratory volume in the 1st second
VC  vital capacityM:F ratio 4:1). The age of the patients was 45 to 72 years (median 6
The Journal of Thoracicge of 57 years). There were 20 patients (57.1%) aged 40 to 60
ears and 15 patients (42.9%) aged more than 60 years. Right-
ided tumors were present in 21 patients (60%), and left-sided
umors were present in 14 patients (40%). The demographics of the
tudy and control groups are presented in Table 1.
Only patients with a diagnosis of COPD based on GOLD
riteria8 were included in the study. Patients were classified in the
OPD group if 100 FEV1/VC was less than 70%; mild, moderate,
evere, and very severe COPD corresponds to an FEV1 greater
han 80%, 50% to 80%, 30% to 50%, and less than 30%,
espectively.
In the analyzed group, obstructive, restrictive, and mixed ven-
ilatory disorders were present on admission in 32 patients
91.4%), 2 patients (5.7%), and 1 patient (2.9%), respectively.
rading of severity of the COPD was based on GOLD criteria. Of
2 patients with COPD, moderate disease was observed in 20
atients, and severe disease was observed in 12 patients. Absolute
nd percent values of FEV1 and VC were below limiting values for
irect referral to surgery in 2 patients with restrictive ventilatory
isorders on admission; dominantly obstructive ventilatory disor-
ers were observed with an FEV1 of 45% of predicted in 1 patient
ith mixed disorders. Thus, 27 patients (77.14%) in the analyzed
roup had moderate to severe COPD according to GOLD criteria.
Lobectomy was performed in 25 patients (71.4%), and pneu-
onectomy was performed in 10 patients (28.6%). A right upper
3-sleeve) lobectomy was performed in 9 patients, a right lower
obectomy was performed in 6 patients, and a middle lobectomy
as performed in 1 patient. A left upper lobectomy was performed
n 3 patients, and a left lower lobectomy was performed in 4
atients. Lobectomy associated with chest wall resection was
erformed in 2 patients. Left and right-sided operations were
qually distributed in 10 patients with pneumonectomy.
No significant comorbidity was observed in 19 patients (54.28%)
n the analyzed group. Accompanying cardiovascular diseases were
emonstrated in 7 patients (20%) (cardiac arrhythmia in 5 patients,
yocardiopathy with arrhythmia in 1 patient, and previous myo-
ardial infarction in 1 patient). Two patients (5.71%) had diabetes,
rterial hypertension, and gastric ulcer. In the remaining 3 patients
8.58%), less significant comorbidity was observed.
The control group consisted of 47 patients with normal lung
unction who underwent lung resection for non–small cell lung
ancer. The mean age of patients was 63.95 years, with 2 patients
4.26%) aged less than 40 years, 28 patients (59.57%) aged 50 to
ABLE 1. Structure of analyzed groups
Main group Control group
o. of patients 35 47
:F 4:1 5.8:1
ge (y)
40 0 2 (4.26%)
41–60 20 (57.1%) 28 (59.57%)
60 15 (42.9%) 17 (36.57%)
ung resection
Lobectomy 25 (3sleeve) 22
Pneumonectomy 10 250 years, and 17 patients (36.57%) aged more than 60 years. In this
and Cardiovascular Surgery ● Volume 134, Number 5 1293
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G
TSroup, lobectomy was performed in 22 patients and pneumonec-
omy was performed in 25 patients. There were 5 right upper and
right lower lobectomies, and 1 patient underwent a middle
obectomy. In patients with left-sided tumors, 6 upper and 5 lower
obectomies were performed, and 1 patient underwent lobectomy
ith a chest wall resection. In patients with pneumonectomy, there
ere 6 right-sided and 19 left-sided operations.
reoperative Workup
n the basis of the respiratory function test results on admission,
ll patients in the main group received combined bronchodilator
herapy consisting of intravenous administration of theophylline
erivatives twice per day (daily dose 2  25 mg or 2  12.5 mg)
nd inhaled bronchodilators 2 to 3 times per day. Physiotherapy
as applied in all patients in the preoperative period (aerosol
herapy, breathing and chest wall-expanding exercises, techniques
f the forced expiration) and early postoperative period (improve-
ent of the peripheral circulation, techniques of diaphragmatic
reathing, inhalations, and expectoration with the aid of the
herapist).
Control spirometry was performed 7 to 10 days after initiation
f the treatment. Patients with FEV1 and 100 FEV1/VC greater
han 60% at control spirometry and without auscultatory signs of
bstruction of the air-flow on physical examination were referred
irectly to surgery. Nine patients in the analyzed group, with FEV1
nd 100 FEV1/VC less than 60% at control spirometry, underwent
erfusion scintigraphy of the lungs with quantification of the
erfusion of each lung to calculate the predicted postoperative
EV1. They were referred to surgery because their postoperative
EV1 was greater than 30% of predicted. The calculation of the
ostoperative FEV1 was performed by using the stepwise method
roposed by Bolliger and colleagues,9 consisting of calculating the
redicted loss of lung function and subtracting the obtained value
rom the measured preoperative FEV1 value.
ata Analysis
he type of ventilatory disorder was correlated to different cate-
ories of radiographic and bronchoscopic findings. Preoperative
ABLE 2. Lung function changes in patients with limited a
Limited lung function
Mean SD
reoperative FEV1 1598.8 391.56
reoperative VC 3042.4 808.48
reoperative FEF50 22.95 10.91
reoperative FEF25 25.42 13.30
FEV1 11.88 12.94
VC 15.69 16.90
FEF50 18.14 88.73
FEF25 25.59 81.56
(l:n) FEV1: 0.006; VC: 0.393; FEF50: 0.024; FEF25: 0.149
D, Standard deviation; FEV1, forced expiratory volume in the 1st second; FE
EV1 (mL) before versus FEV1 (mL) after lobectomy.  VC: percent differe
ifference between FEF50 (%) before versus FEF50 (%) after lobectomy.
obectomy. (l:n): patients with limited lung function versus patients with nbsolute and percent values of FEV1, VC, forced expiratory flows f
294 The Journal of Thoracic and Cardiovascular Surgery ● Novt 50% and 25% VC (FEF50 and FEF25), and 100 FEV1/VC were
ompared with their postoperative values. The differences between
reoperative and postoperative values of FEV1, VC, FEF50, and
EF25 were calculated and statistically analyzed depending on the
xtent of the lung resection (lobectomy vs pneumonectomy).
The differences among FEV1, VC, FEF50, FEF25, and 100
EV1/VC on admission and after combined bronchodilator therapy
ere calculated and statistically analyzed for the entire group and
ccording to the bronchoscopic aspect. The group of patients with
imited lung function was compared with the control group in
erms of perioperative mortality and morbidity (death or compli-
ations within 30 days after the operation). The paired-samples t
est, Mann–Whitney U test, and chi-square test were used.
esults
entilatory Disorders and Bronchoscopic Aspect
n patients with obstructive disorders, no endobronchial or
xtrabronchial tumor growth was observed in 17 patients
53.1%); endobronchial tumor growth was observed in 8
atients (25%), and infiltrative stenosis of the bronchus was
bserved in 7 patients (21.9%). Endobronchial tumor
rowth was observed in 1 of 2 patients with restrictive
isorders, and no visible tumor growth was observed in 1
atient.
ostoperative Lung Function Changes
comparison of patients with limited lung function and
atients with normal lung function, related to lung function
hanges after lobectomy, is presented in Table 2. In 3
atients with limited lung function, FEV1 significantly im-
roved after lobectomy compared with preoperative values
34.7%, 38.2%, and 39.6%), probably because of the lung-
olume reduction effect. In the rest of the patients, the mean
ostoperative decrease in FEV1, expressed as percent de-
rease related to preoperative values, was 11.88% versus a
4.6% decrease in patients with lobectomy and normal lung
ormal lung function after lobectomy
Normal lung function
Median Mean SD Median
1640 2852.27 479.34 2640
3090 4071.36 793.19 3840
22.0 64.64 16.94 62.50
23.50 58.77 17.23 59.0
9.78 24.60 11.06 26.65
16.49 20.60 9.79 21.36
6.67 32.31 25.53 37.72
10.00 16.38 32.47 23.53
ced expiratory flow; VC, vital capacity.  FEV1: percent difference between
etween VC (mL) before versus VC (mL) after lobectomy.  FEF50: percent
25: percent difference between FEF25 (%) before versus FEF25 (%) after
lung function.nd n
F, for
nce b
 FEFunction (P  .05).
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G
TSThe postoperative change in VC followed the same pat-
ern, but the mean postoperative decrease of 15.69% in
atients with limited lung function was not significantly
ower compared with the mean VC decrease of 20.6% in
atients with normal lung function.
In patients with limited lung function, FEF at low lung
olumes (FEF50, FEF25) improved after lobectomy. In pa-
ients with normal lung function, both FEF50 and FEF25
ecreased after lobectomy. The 18.14% improvement of
EF50 in the main group was statistically significant. In
atients with COPD, a 25.59% increase in FEF25 after
obectomy was not statistically significant.
The perfusion pattern of 3 patients whose FEV1 im-
roved postoperatively is presented in Table 3. In all 3 of
hese patients, perfusion defects corresponded to the tumor-
earing lobes, representing 14.2%, 32%, and 15% of the
otal perfusion of the diseased lungs. Tumor perfusion de-
ects were localized in the left lower lobe (patient 1), right
pper lobe (patient 2), and right middle-lower lobe
patient 3). Also, in all 3 patients, the perfusion of the
ealthy lung was better compared with that of the diseased
ung.
ABLE 3. Perfusion scans in three patients with improved
orced expiratory volume at 1 second postoperatively
% Perfusion
atient
o.
Diseased
lung
Healthy
lung PD (%)*
PD corresponds
to tumor
localization
1 42 58 14.2 Yes
2 47 53 32 Yes
3 45.8 54.2 15 Yes
D, Perfusion defect. *Perfusion defect expressed as percent of perfusion
f the ipsilateral lung.
ABLE 4. Lung function changes in patients with limited a
Limited lung function
Mean SD
reoperative FEV1 1912 546.32
reoperative VC 3305 1262.30
reoperative FEF50 35.42 19.25
reoperative FEF25 37.90 22.37
FEV1 17.88 31.35
VC 23.20 55.00
FEF50 21.31 84.55
FEF25 18.83 97.08
(l:n) FEV1: 0.046; VC: 0.689; FEF50: 0.126; FEF25: 0.522
D, Standard deviation; FEV1, forced expiratory volume in the 1st second; FE
EV1 (mL) before versus FEV1 (mL) after pneumonectomy.  VC: percent dif
ercent difference between FEF (%) before versus FEF (%) after pneum50 50
%) after pneumonectomy. (l:n): patients with limited lung function versus patie
The Journal of ThoracicA comparison between patients with limited and normal
ung function, related to lung function changes after pneu-
onectomy, is presented in Table 4.
The pattern of lung function change after pneumonec-
omy in patients with limited lung function followed the
ame trend as that after lobectomy: significantly smaller
ecrease in FEV1 compared with the control group (17.88%
s 42.51%) and evidently (but not significantly) smaller
ecrease in VC and improvement of FEF50 and FEF25. In
atients who underwent a pneumonectomy, the 23.31%
ean improvement of FEF50 in those with COPD was not
tatistically significant. The FEV1 at 25% VC also improved
n the main group, but the differences between groups were
ot significant.
In 8 patients who underwent a pneumonectomy, we ana-
yzed the differences between predicted FEV1 based on ven-
ilation/perfusion scans and FEV1 measured postoperatively,
xpressed as  percent differences related to predicted
ostoperative FEV1. Differences between predicted and
easured values of less than 5%, 6% to 10%, 11% to 20%,
nd more than 20% were observed in 2, 1, 2, and 3 patients,
espectively.
ung Function Changes After Combined
ronchodilator Therapy
he differences between values of ventilatory parameters
efore and after bronchodilator therapy are presented in
able 5. Both the mean improvement of FEV1 in milliliters
416.6 mL) and the FEV1 percent improvement (14.16%)
ere statistically significant compared with values on
dmission.
Only the VC percent improvement of 13% was statisti-
ally significant related to the VC baseline values.
The Tiffeneau index (100 FEV1/VC) increased from a
ean value of 52.3% before treatment to 57.6% after treat-
ent (P  .05), indicating the switch of the overall venti-
ormal lung function after pneumonectomy
Normal lung function
Median Mean SD Median
1850 2934.50 615.98 2690
3475 4163 879.14 4120
31.65 63.50 25.15 57.50
33.05 64.10 32.38 54.50
31.33 42.51 12.98 43.46
43.89 43.74 10.09 45.71
9.38 36.11 30.63 45.83
5.13 22.82 59.21 32.56
ced expiratory flow; VC, vital capacity.  FEV1: percent difference between
e between VC (mL) before versus VC (mL) after pneumonectomy.  FEF50:
tomy.  FEF : percent difference between FEF (%) before versus FEFnd n
F, for
ferenc
onec 25 25 25
nts with normal lung function.
and Cardiovascular Surgery ● Volume 134, Number 5 1295
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G
TSatory disorders from moderate and severe to mild COPD or
estriction.
The mean increase in FEF50 from 24.37%  11.36% to
1.75%  12.33% was statistically significant. The mean
ncrease in FEF25 from 26.97%  13.87% to 32.64% 
4.49% approached statistical significance (P  .55).
perative Mortality and Morbidity
n both the main and control groups, no deaths occurred
ithin the first 30 postoperative days. In the same period, 12
f 344 patients who underwent operation died during the
rst 30 postoperative days, thus representing an operative
ortality of 3.1%.
In the group of 35 patients with limited lung function,
ifferent postoperative complications occurred in 18 pa-
ients (51.43%). Postoperative complications occurred in 15
atients who underwent lobectomy and in 3 patients who
nderwent pneumonectomy. In patients who underwent lo-
ectomy, prolonged air leak occurred in 11 patients (44%)
associated with arrhythmia in 1 patient), pulmonary embo-
ism occurred in 1 patient, and pneumothorax occurred in 1
atient 8 days after the removal of chest tubes when stable
ung expansion was achieved. The only case of respiratory
nsufficiency occurred in a patient with lobectomy. Gastric
tress ulcer occurred in 1 patient. Among those who under-
ent pneumonectomy, arrhythmia occurred in 2 patients,
nd bronchopleural fistula occurred in 1 patient with a left
neumonectomy.
Of a total of 19 of 35 patients (54.28%) with no preop-
rative comorbidity, no postoperative complications were
egistered in 11 of 19 patients (57.89%). Of 7 patients at
ABLE 5. Lung function in patients with chronic obstruc-
ive pulmonary disease before and after bronchodilator
herapy
Mean SD Mean  t
Significance
(2-tailed)
EV1 (mL) A 1658.14 504.91 416.66 7.120 .000
EV1 (mL) B 2074.81 465.28
EV1 (%) A 55.25 15.42 14.16 7.14 .000
EV1 (%) B 69.41 14.88
C (%) A 83.94 22.67 13.05 4.39 .000
C (%) B 97.00 14.88
iffeneau A 52.30 12.40 5.37 2.59 .01
iffeneau B 57.67 9.30
EF50 (%) A 24.37 11.36 7.38 3.49 .002
FEF50 (%) B 31.75 12.33
FEF25 (%) A 26.97 13.87 5.66 .05
EF25 (%) B 32.64 14.49
D, Standard deviation; FEV1, forced expiratory volume in the 1st second;
EF, forced expiratory flow; VC, vital capacity. A: before therapy; B: after
herapy. mean : mean change (in milliliters or percent).ncreased cardiac risk preoperatively, the postoperative S
296 The Journal of Thoracic and Cardiovascular Surgery ● Novourse was uneventful in only 1 patient. In the remaining 6
atients, prolonged air leak and arrhythmia occurred in 1
atient each, and both complications occurred in 1 patient.
Postoperative complications occurred in 15 patients
31.9%) in the control group. In patients with lobectomy,
rolonged air leak occurred in 4 of 22 patients (18.2%) and
rrhythmia occurred in 3 of 22 patients (13.6%). In the
neumonectomy group, bronchopleural fistula and empy-
ma without fistula occurred in 1 of 25 patients (4%). Other
omplications included arrhythmia in 5 patients (2 with
ife-threatening arrhythmia) and prolonged postoperative
ourse with elevated body temperature in 1 patient.
Potentially life-threatening cardiopulmonary complica-
ions (embolism, respiratory insufficiency, and bronchopleural
stula) occurred in 5 patients (14.3%) in the main group and in
patients (6.38%) in the control group (P  .05).
iscussion
nclusion Criteria and Preoperative Workup
wo points should be addressed when discussing surgical
reatment in patients with limited lung function. First, the
utoff values and grading of severity of COPD differ
hroughout the literature. In some studies, COPD is defined
s the percentage of predicted FEV1 less than or equal to
0% and the percentage of FEV1/FVC less than or equal to
0%.10,11 In other studies, COPD is defined by only the
EV1/FVC being less than 70%.12 Cutoff values for preop-
rative FEV1 as criteria for impaired lung function vary
rom an FEV1 of 1 liter or less up to 80% of predicted.13
urthermore, the influence on morbidity, mortality, and
urvival is analyzed between patients with COPD and pa-
ients without COPD, or between COPD subgroups (mild/
oderate) and non-COPD subgroups.14 These method-
logic differences could influence the obtained results. In
he present study, in addition to the fact that COPD is not
he only criterion for limited lung function, in order to avoid
andomly determined cutoff values, we included only pa-
ients in whom the GOLD criteria for moderate to severe
OPD could be applied.
Second, although the role of smoking cessation before
ung resection is still not clear, it was obligatory in the
nalyzed group. Tobacco smoke directly stimulates reten-
ion of secretion and atelectasis that may be life-threatening
n these patients either directly (leading to worsening of
xygenation) or indirectly (by inducing cardiac arrhyth-
ias). Furthermore, radical lymphadenectomy causes vagal
enervation with possible hyposaturation even in nonsmok-
rs, whereas the impaired lung vascularization in patients
ith COPD favors prolonged air leak after the operation.15
he addition of the harmful effect of the tobacco smoke to
he aforementioned factors significantly influences the lung
unction in the immediate and early postoperative periods.
uch an attitude is supported by studies suggesting that
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G
TSmoking cessation should be encouraged because it may
ecrease postoperative inflammation and in the long-term
ay decrease the risk of recurrence.16
ung Function Changes After Resection
ostoperative changes in FEV1 and VC values in both the
nalyzed and control groups confirmed the relatively
ild permanent lung function loss after lobectomy, un-
ike the early permanent loss in lung function of approx-
mately 33% that occurs after pneumonectomy.17 In the
nalyzed group, the loss in FEV1 was significantly lower
han that in the control group of patients with normal lung
unction, both in patients with lobectomy and pneumo-
ectomy. A similar finding was demonstrated in a recent
tudy performed by Baldi and colleagues.18 In 88 patients
ith COPD, they demonstrated that in patients with
OPD, the delayed FEV1 deficit after lobectomy was
maller compared with patients without COPD who un-
erwent operation. Controlled studies that could explain
uch results are rare. One of these is a prospective study
f 16 patients19 demonstrating that the initial decrease in
ffort tolerance was probably the result of circulatory and
entilatory disturbances, whereas the recovery after 1
onth ensued because of the improvement of the venti-
atory component, initially disturbed by the operative
rauma to the thoracic wall. Similar results were obtained
n the study by Santambrogio and colleagues20 of 42
atients with COPD and 45 patients without COPD. In
his study, the decrease in FEV1 6 months after the
peration in the COPD and non-COPD groups was 3.2%
nd 14.9%, respectively.
One of the most important results of the current study is
significant improvement of the function of small airways
ie, of the airflow at low lung volumes: FEF50 and FEF25)
egistered after lobectomy in patients with limited lung
unction. Although the same trend of improvement was also
egistered after pneumonectomy, it was statistically signif-
cant only after lobectomy. Although the postoperative
hange of the small airways function was not separately
nalyzed in most studies dealing with this problem, the
btained results are of practical interest because of the direct
nfluence on the pattern of postoperative lung function
hange and the favorable influence on perioperative mor-
idity and mortality.
The obtained results are of interest for preoperative
atient selection. Because of the aforementioned dynam-
cs in lung function change, a select number of patients,
therwise not suitable candidates for surgery based on
ung function assessment, could be offered surgery.
perative Mortality and Morbidity
ur finding that no patients died within the first 30 postop-rative days, although relatively unexpected, was registered o
The Journal of Thoracicn the period in which the overall operative mortality cal-
ulated to all lung resections was 3.1%, which corresponds
o most literature data.21,22 The results of studies comparing
perative mortality and morbidity in patients with limited
ung function are contradictory. However, most of them
onfirmed that patients with COPD were exposed to the
ncreased risk of postoperative complications. In a study on
0 patients with COPD who underwent operation, the sig-
ificant impairment of the gas exchange during 1-lung ven-
ilation was demonstrated, which was more severe in the
ight thoracotomy than in the left thoracotomy.23 In one of
he largest studies on this issue (181 patients with COPD),
he operative morbidity and mortality were 42.3% and
.9%, respectively, and cardiopulmonary complications
ere more frequently associated with lobectomy than with
neumonectomy (48.3% vs 25.6%, respectively).24 Other
tudies showed the presence of 2 or more concomitant
iseases and a performance status of grade 2 or higher as
ssential in terms of postoperative death, but at the same
ime demonstrated the improvement of pulmonary function
fter lung resection in patients with COPD, as in the afore-
entioned study of Koizumi and colleagues.13 The absence
f perioperative deaths in our study supports the findings of
tudies that did not confirm higher complication rates in
atients with COPD versus those without COPD. In the
forementioned study of Santambrogio and colleagues,20
or example, no difference in operative morbidity, operative
ortality, and survival was registered between 42 patients
ith COPD and 45 patients without COPD.
The absence of difference in operative mortality between
atients with limited and normal lung function in the analyzed
roup may be partly explained by the improvement of the
mall airways function after resection and by the influence of
reoperative bronchodilator therapy on the lung function, both
learly demonstrated in this study. In regard to the improve-
ent in the small airways function, it could be one of the
ignificant factors helping patients to overcome the initial loss
f lung function in the immediate and early postoperative
eriod by minimizing decreases in saturation that sometimes
ccur in patients with incomplete lung expansion immediately
fter resection. Our finding that prolonged air leak or arrhyth-
ia occurred postoperatively in 6 of 7 patients at increased
ardiac risk underlines the need for optimizing lung ventilation
n the early postoperative course.
Although there is still some concern among clinicians in
egard to the real benefit of preoperative bronchodilator
herapy, our results clearly demonstrate the significant im-
rovement of most of the lung function parameters after
ronchodilator therapy. It is likely that this improvement, in
oth the FEV1 and the function of the small airways, act in
he same way as the previously described mechanism. From
he standpoint of the surgical technique, correct aerostasis is
f the utmost importance in patients with COPD.
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G
TSOn the other hand, the current study with an operative
orbidity of 51.43% demonstrated the more frequent oc-
urrence of postoperative complications in patients with
OPD than in those without COPD, thus confirming the
ajority of literature data. The distribution of complications
n our group was as expected, with 44% representing pro-
onged air leak and approximately 14.3% representing car-
iorespiratory complications.
Postoperatively, priority was given to the immediate
limination of residual air and liquid collections by reinser-
ion of new, narrower caliber chest tubes and quick removal
f large, intraoperatively inserted chest tubes. Even with
uch a policy, 11 patients (31.4%) had prolonged air leak,
ut without major influence to the outcome of the treatment.
hysiotherapy was routine in these patients, and any manifest
r imminent atelectasis was solved by fiberbronchoscopic as-
iration. In all patients with COPD, low-molecular-weight
eparin was introduced 6 hours after the operation and contin-
ed for 6 to 7 postoperative days.
No routine bronchial stump coverage was performed
fter pneumonectomy in patients with limited lung function.
he only bronchopleural fistula that occurred in a patient
ith left pneumonectomy was a consequence of an exces-
ive dissection and a short bronchial stump with tension to
he suture line rather than of impaired vascularization
aused by COPD. Nevertheless, some form of bronchial
tump protection, at least in patients with COPD undergoing
neumonectomy, may be recommended.25
One possible explanation for the increased operative
orbidity in patients with COPD may be found in a recent
tudy performed at The University of Texas Health Science
enter in Houston on 1334 patients who underwent opera-
ion. In this study, 41% of patients with an FEV1 of 60% to
0% had a postoperative FEV1 of less than 40%, and 26%
f patients had a postoperative FEV1 of less than 35%.
pproximately one third of patients with an FEV1 of more
han 2 liters would have been deemed ineligible for pneu-
onectomy on the basis of a postoperative FEV1 of less
han 40%.26 Because split-lung function tests are not rou-
inely performed in many centers, even in patients with an
EV1 of less than 60%, overestimation of postoperative
ung function may be one of the causes of the increased
ostoperative morbidity.
onclusions
his study demonstrated a different pattern of lung function
hange after lung resection between patients with limited
ung function and patients with normal lung function. In
atients with COPD, the loss of FEV1 was significantly
maller, whereas the function of the small airways improved
fter lung resection compared with patients with normal
ung function. Surgery should not be rejected for patients
ith lung cancer and limited lung function unless additional
1
298 The Journal of Thoracic and Cardiovascular Surgery ● Novung function assessment is performed. Operative mortality
nd morbidity in patients with COPD are comparable to
hose in patients with normal lung function.
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